Sponsor:Annexon, Inc.Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of Intravenous ANX005…
Sponsor:Mayo ClinicBrief Summary: ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through…
Sponsor:Merit E. Cudkowicz, MDBrief Summary: The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety…
Sponsor:BiogenBrief Summary: The primary objective is to evaluate the long-term safety and tolerability of BIIB078 in participants with chromosome 9…
Sponsor:Mitsubishi Tanabe Pharma America Inc.Brief Summary: REFINE-ALS is a prospective, observational, longitudinal, multicenter study designed to identify biomarkers to serve…
Sponsor:Alexion PharmaceuticalsBrief Summary: The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment…
Sponsor:ProgenaBiomeBrief Summary: This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding…
Sponsor:Loma Linda UniversityBrief Summary: This study is being conducted to help the investigators better understand how the new FDA approved…
Sponsor:MediciNovaBrief Summary: A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of…
Sponsor:Powell Mansfield Inc.Brief Summary: This is a pilot study to examine the diagnostic utility of a novel transmembrane surface sensor,…
